NCT02229773View on ClinicalTrials.gov

Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

May 31, 2000

Conditions
Healthy
Interventions
DRUG

BIBB 1464 MS low dose

DRUG

Placebo

DRUG

Pravastatin

DRUG

BIBB 1464 MS medium dose

DRUG

BIBB 1464 MS high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY